Advertisement

Lee J, Zhang LL, Wu W, et al. Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma. Blood Adv. 2018;2(16):2039-2051.

On page 2039 in the 28 August 2018 issue, the byline and author affiliations omitted an author, Shengjian Huang. The byline and author affiliations should read:

Jimmy Lee,1,* Liang Leo Zhang,2,* Wenjun Wu,1 Hui Guo,2 Yan Li,3 Madina Sukhanova,4 Girish Venkataraman,1 Shengjian Huang,2 Hui Zhang,2 Mir Alikhan,5 Pin Lu,1 Ailin Guo,1 Natalie Galanina,6 Jorge Andrade,3 Michael L. Wang,2 and Y. Lynn Wang1

1Lymphoma Translational Pathology, Department of Pathology, University of Chicago, Chicago, IL; 2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX; 3Center for Research Informatics and 4Department of Pediatrics, University of Chicago, Chicago, IL; 5Department of Pathology, NorthShore University HealthSystem, Evanston, IL; and 6Department of Medicine, University of California, San Diego, CA

On page 2049, under “Authorship,” the contribution paragraph should read, “Y.L.W. formed the hypothesis and directed the project; J.L., L.L.Z., W.W., H.G., M.S., G.V., S.H., H.Z., P.L., A.G., and N.G. developed the assays, designed and performed the experiments, solved technical problems, and analyzed the data; M.A. participated in IHC review and data presentation; L.L.Z., M.S., G.V., and M.L.W. contributed useful patient materials and patient pathological and treatment information; L.L.Z. and M.L.W. designed and performed the PDX study; Y.L. and J.A. performed bioinformatics analyses on the RNA-Seq data; J.L. L.L.Z., P.L., and J.A. participated in the manuscript writing; and Y.L.W. directed and coordinated the project, designed the experiments, analyzed the data, and wrote the manuscript.”

The errors have been corrected in the published article.

  • Submitted September 20, 2018.
  • Accepted September 20, 2018.